Approval · Notice of Compliance 19086 · 2017
RAPIVAB: Notice of Compliance 19086
Issued March 21, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19086
- Date
- March 21, 2017
- Company
- Seqirus Uk LimitedMaidenhead, Berkshire, United Kingdom
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAPIVAB | 02460319 | Approved |
Medicinal ingredients
- PERAMIVIR 10 MG per ML